Project Number 1R41NS127666-01A1 Agency/Funding Organization NINDS Funding Year 2022 View Full Project Details for Therapeutic Reduction of Cerebral Amyloid Angiopathy Pathologies in ADRD Research Categorization Primary Disease / Condition Vascular Dementia/Dysfunction Alzheimer's Disease CADRO Category A. Molecular Pathogenesis and Physiology of Alzheimer's Disease and Alzheimer's Disease-related Dementias (AD/ADRDs) 11. Vascular Etiology e. Cerebral Amyloid Angiopathy Researcher and Organization Principal Investigator VITEK, MICHAEL P. Principal Investigator First Name MICHAEL P. Principal Investigator Last Name VITEK Awardee Organization REGENNOVA, INC. Awardee State North Carolina Contact PI Country United States Project Detail Funding Opportunity Announcement PAS-19-317: Advancing Research on Alzheimer's Disease (AD) and Alzheimer's-Disease-Related Dementias (ADRD) (R41/R42 Clinical Trial Optional) FY Overall Cost $499,900 Funding Organization Agency/Funding Organization NINDS Funding Organization Country United States Program Official GILCHRIST, FLOY ANNETTE
